Clinical trial
Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)
NCT01774630 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 10, 2013
- Completion date
- December 21, 2020
- Enrollment
- 31 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.